Total Payments
$107,504
2024 Payments
$70,398
Companies
14
Transactions
99
Medicare Patients
1,917
Medicare Billing
$156,977
Payment Breakdown by Category
Consulting$60,978 (56.7%)
Other$39,453 (36.7%)
Travel$4,089 (3.8%)
Food & Beverage$2,891 (2.7%)
Education$93.89 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $60,978 | 15 | 56.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,013 | 7 | 32.6% |
| Honoraria | $4,440 | 2 | 4.1% |
| Travel and Lodging | $4,089 | 12 | 3.8% |
| Food and Beverage | $2,891 | 60 | 2.7% |
| Education | $93.89 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $36,906 | 19 | $0 (2024) |
| LEO Pharma Inc. | $29,407 | 25 | $0 (2024) |
| GENZYME CORPORATION | $29,045 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11,108 | 5 | $0 (2024) |
| PFIZER INC. | $259.53 | 3 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $165.42 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $126.68 | 5 | $0 (2024) |
| Celgene Corporation | $104.57 | 1 | $0 (2017) |
| Incyte Corporation | $91.07 | 2 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $87.25 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70,398 | 50 | Galderma Laboratories, L.P. ($36,866) |
| 2023 | $34,642 | 42 | GENZYME CORPORATION ($19,663) |
| 2022 | $2,284 | 4 | GENZYME CORPORATION ($2,196) |
| 2020 | $14.80 | 1 | AbbVie Inc. ($14.80) |
| 2017 | $165.38 | 2 | Celgene Corporation ($104.57) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,430.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,416.00 | General |
| Category: Immunology | ||||||
| 11/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Galderma Laboratories, L.P. | — | Consulting Fee | Cash or cash equivalent | $5,550.00 | General |
| 11/04/2024 | LEO Pharma Inc. | ADBRY (Biological) | Travel and Lodging | In-kind items and services | $791.40 | General |
| Category: DERMATOLOGY | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,416.00 | General |
| Category: Immunology | ||||||
| 10/26/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Inflammation & Immunology | ||||||
| 10/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $98.91 | General |
| Category: Dermatology | ||||||
| 10/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $31.34 | General |
| Category: Dermatology | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: Immunology | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: Immunology | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $188.83 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Galderma Laboratories, L.P. | — | Consulting Fee | In-kind items and services | $119.19 | General |
| 10/24/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $70.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $59.73 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $34.82 | General |
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $12.81 | General |
| 10/09/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| 10/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: DERMATOLOGY | ||||||
| 09/18/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,300.00 | General |
| 09/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,073.00 | General |
| Category: DERMATOLOGY | ||||||
| 09/18/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| 09/18/2024 | Galderma Laboratories, L.P. | — | Travel and Lodging | In-kind items and services | $316.50 | General |
| 09/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 989 | 1,254 | $214,367 | $69,389 |
| 2022 | 8 | 321 | 509 | $218,439 | $37,109 |
| 2021 | 8 | 341 | 481 | $206,240 | $33,938 |
| 2020 | 8 | 266 | 374 | $152,645 | $16,541 |
Total Patients
1,917
Total Services
2,618
Medicare Billing
$156,977
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 256 | $43,776 | $16,730 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 176 | $44,176 | $16,597 | 37.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 109 | 111 | $28,527 | $7,841 | 27.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 148 | 154 | $25,718 | $5,956 | 23.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 64 | 71 | $20,377 | $5,925 | 29.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 65 | 65 | $16,380 | $5,411 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $13,022 | $4,335 | 33.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 15 | $6,795 | $2,029 | 29.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 97 | 292 | $4,672 | $1,476 | 31.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 16 | $5,168 | $1,408 | 27.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 24 | 27 | $3,699 | $1,063 | 28.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $1,573 | $484.33 | 30.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 12 | $444.00 | $121.22 | 27.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 14 | $39.80 | $11.58 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 166 | $95,782 | $18,613 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 76 | $29,868 | $5,797 | 19.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 33 | 34 | $21,760 | $3,033 | 13.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 22 | 26 | $18,174 | $2,835 | 15.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 44 | 54 | $25,164 | $2,386 | 9.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $10,350 | $1,885 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $12,138 | $1,826 | 15.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 28 | 121 | $5,203 | $733.36 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 105 | $60,585 | $11,896 | 19.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 99 | $38,907 | $7,410 | 19.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $26,877 | $4,419 | 16.4% |
About Dr. Daniel Butler, M.D
Dr. Daniel Butler, M.D is a Internal Medicine healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2014. The National Provider Identifier (NPI) number assigned to this provider is 1013320738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Butler, M.D has received a total of $107,504 in payments from pharmaceutical and medical device companies, with $70,398 received in 2024. These payments were reported across 99 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($60,978).
As a Medicare-enrolled provider, Butler has provided services to 1,917 Medicare beneficiaries, totaling 2,618 services with total Medicare billing of $156,977. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location San Francisco, CA
- Active Since 06/10/2014
- Last Updated 09/26/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013320738
Products in Payments
- DUPIXENT (Biological) $29,177
- ADBRY (Biological) $14,809
- SPEVIGO (Drug) $11,108
- CIBINQO (Drug) $189.09
- Otezla (Drug) $104.57
- Zoryve (Drug) $98.91
- OPZELURA (Drug) $91.07
- LITFULO (Drug) $70.44
- LIBTAYO (Biological) $46.00
- SKYRIZI (Biological) $34.94
- ILUMYA (Biological) $33.20
- VTAMA (Drug) $30.47
- RINVOQ (Biological) $29.11
- HUMIRA (Biological) $14.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Francisco
Dr. Fred Cohen, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
John Teerlink, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Kenneth Binmoeller, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Hope Rugo, Md, MD
Internal Medicine — Payments: $881,117
Internal Medicine $881,117
Dr. Steven Harris, M.d, M.D
Internal Medicine — Payments: $806,637
Internal Medicine $806,637
Dr. Kenneth Colley, Md, MD
Internal Medicine — Payments: $732,736
Internal Medicine $732,736